Published in Biochem Biophys Res Commun on December 19, 1973
Metabolic properties of a homogeneous proteoglycan of a haemopoietic stem cell line, FDCP-mix. Biochem J (1989) 0.85
Developmental regulation of neuraminidase-sensitive lectin-binding glycoproteins during myogenesis of rat L6 myoblasts. Biochem J (1984) 0.79
Developmentally-related changes in surface membrane glycopeptides of murine haemopoietic cells. Biochem J (1987) 0.75
Herpes simplex virus type 1 in brain and risk of Alzheimer's disease. Lancet (1997) 5.47
Identification of a platelet membrane glycoprotein as a falciparum malaria sequestration receptor. Science (1989) 3.83
Molecular basis of sequestration in severe and uncomplicated Plasmodium falciparum malaria: differential adhesion of infected erythrocytes to CD36 and ICAM-1. J Infect Dis (1991) 2.87
Molecular cloning, sequencing, and mapping of EGR2, a human early growth response gene encoding a protein with "zinc-binding finger" structure. Proc Natl Acad Sci U S A (1988) 2.73
Cytokines and arachidonic metabolites produced during human immunodeficiency virus (HIV)-infected macrophage-astroglia interactions: implications for the neuropathogenesis of HIV disease. J Exp Med (1992) 2.48
Identification of glycoprotein IV (CD36) as a primary receptor for platelet-collagen adhesion. J Biol Chem (1989) 2.22
Isolation and characterization of plasma membranes from human blood platelets. J Biol Chem (1970) 2.17
Membrane glycoprotein CD36: a review of its roles in adherence, signal transduction, and transfusion medicine. Blood (1992) 2.06
Calcium-dependent affinity chromatography of calmodulin on an immobilized phenothiazine. Biochem Biophys Res Commun (1979) 1.80
Isolation and characterization of platelet glycoprotein IV (CD36). J Biol Chem (1989) 1.68
Isolation and characterization of plasma membranes and intact nuclei from lymphoid cells. J Biol Chem (1977) 1.62
Platelet glycocalicin. Interaction with thrombin and role as thrombin receptor of the platelet surface. J Biol Chem (1978) 1.60
Platelet-activating factor: a candidate human immunodeficiency virus type 1-induced neurotoxin. J Virol (1994) 1.56
Scientific basis for cancer prevention. Intermediate cancer markers. Cancer (1993) 1.47
Novel structurally altered P(2X1) receptor is preferentially activated by adenosine diphosphate in platelets and megakaryocytic cells. Blood (2001) 1.43
Detection of GPIV (CD36) mRNA in Naka- platelets. Thromb Haemost (1991) 1.41
Pomegranate extract inhibits Staphylococcus aureus growth and subsequent enterotoxin production. J Ethnopharmacol (2005) 1.32
Growth control of lung cancer by interruption of 5-lipoxygenase-mediated growth factor signaling. J Clin Invest (1996) 1.27
Platelet glycocalicin: a single receptor for platelet aggregation induced by thrombin or ristocetin. Thromb Res (1976) 1.26
Characterization of S-100b binding epitopes. Identification of a novel target, the actin capping protein, CapZ. J Biol Chem (1995) 1.25
The glycocalicin portion of platelet glycoprotein Ib expresses both high and moderate affinity receptor sites for thrombin. A soluble radioreceptor assay for the interaction of thrombin with platelets. J Biol Chem (1986) 1.25
Platelet glycocalicin. I. Orientation of glycoproteins of the human platelet surface. J Biol Chem (1976) 1.24
Platelet glycocalicin. II. Purification and characterization. J Biol Chem (1976) 1.24
Enzymatic basis for platelet: collagen adhesion as the primary step in haemostasis. Nat New Biol (1971) 1.23
Sequestrin, a CD36 recognition protein on Plasmodium falciparum malaria-infected erythrocytes identified by anti-idiotype antibodies. Proc Natl Acad Sci U S A (1991) 1.22
Reduced thrombin binding and aggregation in Bernard-Soulier platelets. J Clin Invest (1978) 1.22
Structure and function relationships among calmodulins and troponin C-like proteins from divergent eukaryotic organisms. Ann N Y Acad Sci (1980) 1.18
Platelet collagen adhesion characterization of collagen glucosyltransferase of plasma membranes of human blood platelets. Biochim Biophys Acta (1971) 1.17
Platelet membrane glycoproteins in thrombasthenia, Bernard-Soulier syndrome, and storage pool disease. J Lab Clin Med (1979) 1.17
Five-lipoxygenase inhibitors can mediate apoptosis in human breast cancer cell lines through complex eicosanoid interactions. FASEB J (2001) 1.17
A platelet membrane glycoprotein (GP) deficiency in healthy blood donors: Naka- platelets lack detectable GPIV (CD36). Blood (1990) 1.15
Presence of calmodulin in Tetrahymena. Proc Natl Acad Sci U S A (1979) 1.09
Tissue factor in microvesicles shed from U87MG human glioblastoma cells induces coagulation, platelet aggregation, and thrombogenesis. Blood (1984) 1.09
Functional elimination of calmodulin within the nucleus by targeted expression of an inhibitor peptide. J Biol Chem (1995) 1.04
The carbohydrate sequence of the glycopeptide chains of human transferrin. J Biol Chem (1971) 0.99
Calmodulin confers calcium sensitivity on ciliary dynein ATPase. J Cell Biol (1980) 0.99
Isolation of a macroglycopeptide from human platelets. Biochemistry (1970) 0.99
Isolation of glycopeptides from low- and high-density platelet plasma membranes. Biochemistry (1971) 0.99
The effects of various lectins on platelet aggregation and release. Biochim Biophys Acta (1974) 0.98
Antigenic and functional differences in adhesion of Plasmodium falciparum-infected erythrocytes to human and bovine CD36. Infect Immun (1993) 0.98
Adhesive functions of platelets lacking glycoprotein IV (CD36). Blood (1991) 0.98
Mitogen stimulation of Na+-H+ exchange: differential involvement of protein kinase C. Am J Physiol (1987) 0.97
Expression of functional HIV-1 integrase in the yeast Saccharomyces cerevisiae leads to the emergence of a lethal phenotype: potential use for inhibitor screening. Curr Genet (1996) 0.97
Anti-CD36 antibodies in thrombotic thrombocytopenic purpura. Br J Haematol (1994) 0.96
Glycoprotein Ib (GPIb)-dependent and GPIb-independent pathways of thrombin-induced platelet activation. Blood (1991) 0.96
Expression pattern of fatty acid-binding proteins in human normal and cancer prostate cells and tissues. Clin Cancer Res (2001) 0.96
Platelet adhesion to native type I collagen fibrils. Role of GPVI in divalent cation-dependent and -independent adhesion and thromboxane A2 generation. J Biol Chem (1998) 0.95
Observations in hyperthyroidism of abnormal glucose tolerance and other traits related to diabetes mellitus. Diabetes (1965) 0.94
Transient increase in intracellular pH during Dictyostelium differentiation. J Cell Biol (1984) 0.94
Correlation of phosphoinositide hydrolysis with exflagellation in the malaria microgametocyte. J Parasitol (1994) 0.94
Inhibition of platelet adhesion to collagen by monoclonal anti-CD36 antibodies. Br J Haematol (1996) 0.94
Specificity and Zn2+ enhancement of the S100B binding epitope TRTK-12. J Biol Chem (1999) 0.93
Identification of the platelet-specific alloantigen, Naka, on platelet membrane glycoprotein IV. Blood (1990) 0.93
PPACK-thrombin inhibits thrombin-induced platelet aggregation and cytoplasmic acidification but does not inhibit platelet shape change. Blood (1990) 0.92
Mechanisms of platelet aggregation by human tumor cell lines. Prog Clin Biol Res (1982) 0.91
Characterization of membrane-bound collagen galactosyltransferase of human blood platelets. Biochim Biophys Acta (1971) 0.91
High and moderate affinity pathways for alpha-thrombin-induced platelet activation. Proc Soc Exp Biol Med (1991) 0.91
Studies on glycoproteins. 3. Isolation of sialylglycopeptides from human platelet membranes. Biochemistry (1969) 0.91
Human CD36 deficiency is associated with elevation in low-density lipoprotein-cholesterol. Am J Med Genet (2000) 0.90
Calcium mobilization in permeabilized fibroblasts: effects of inositol trisphosphate, orthovanadate, mitogens, phorbol ester, and guanosine triphosphate. J Cell Physiol (1987) 0.90
Interaction of S100a0 protein with the actin capping protein, CapZ: characterization of a putative S100a0 binding site in CapZ alpha-subunit. Biochem Biophys Res Commun (1996) 0.89
SEB is cytotoxic and alters EC barrier function through protein tyrosine phosphorylation in vitro. Am J Physiol (1997) 0.89
The interaction of platelets, tumor cells, and vascular subendothelium. J Lab Clin Med (1980) 0.89
Glycosphingolipids: the putative receptor for Staphylococcus aureus enterotoxin-B in human kidney proximal tubular cells. Mol Cell Biochem (1992) 0.89
A Note on External Otitis. Br Med J (1946) 0.88
Mitogenic activities of amino acid substitution mutants of staphylococcal enterotoxin B in human and mouse lymphocyte cultures. Infect Immun (1996) 0.88
Type I CD36 deficiency in humans is not associated with insulin resistance syndrome. Thromb Haemost (2000) 0.88
An experimental model system for HIV-1-induced brain injury. Adv Neuroimmunol (1994) 0.88
Mitogen-stimulated release of inositol phosphates in human fibroblasts. Arch Biochem Biophys (1987) 0.87
Structure and function of platelet glycocalicin. Thromb Haemost (1980) 0.87
Thrombin receptors define responsiveness of cholesterol-modified platelets. J Biol Chem (1983) 0.86
S-100 (alpha and beta) binding peptide (TRTK-12) blocks S-100/GFAP interaction: identification of a putative S-100 target epitope within the head domain of GFAP. Biochim Biophys Acta (1996) 0.86
Contributions of glycoprotein Ib and the seven transmembrane domain receptor to increases in platelet cytoplasmic [Ca2+] induced by alpha-thrombin. Biochemistry (1996) 0.86
A comparison of methods for platelet lysis and the isolation of platelet membranes. Thromb Diath Haemorrh (1971) 0.85
Identification of a nucleotide-binding site on glycoprotein IIb. Relationship to ADP-induced platelet activation. J Biol Chem (1991) 0.83
Changes in distribution of platelet membrane glycoproteins in patients with myeloproliferative disorders. Am J Hematol (1977) 0.83
Isolation of a glycoprotein fraction from human platelet membranes which inhibits viral haemagglutination. Nature (1968) 0.83
Study of proinflammatory responses induced by Yersinia pestis in human monocytes using cDNA arrays. Genes Immun (2007) 0.83
Differentiation of platelet-aggregating effects of human tumor cell lines based on inhibition studies with apyrase, hirudin, and phospholipase. Cancer Res (1982) 0.83
Thrombin binding and response in platelets from patients with dyslipoproteinemias: increased stimulus-response coupling in type II hyperlipoproteinemia. Blood (1986) 0.83
Selection of targeted biological modifiers from a bacteriophage library of random peptides. The identification of novel calmodulin regulatory peptides. J Biol Chem (1993) 0.83
Morphometric evaluation of thrombogenesis by microvesicles from human tumor cell lines with thrombin-dependent (U87MG) and adenosine diphosphate-dependent (SKNMC) platelet-activating mechanisms. J Lab Clin Med (1986) 0.83
Characterization of human platelet UDPglucose-collagen glucosyltransferase using a new rapid assay. Biochim Biophys Acta (1977) 0.82
Interaction of human platelets with laminin and identification of the 67 kDa laminin receptor on platelets. Biochem J (1991) 0.82
Thrombin binds to a high-affinity approximately 900 000-dalton site on human platelets. Biochemistry (1985) 0.82
Molecular cloning and brain localization of HZF-2 alpha, a new member of the Rev-erb subfamily of orphan nuclear receptors. J Neurobiol (1997) 0.82
Transcriptome characterization of immune suppression from battlefield-like stress. Genes Immun (2012) 0.82
Method for simultaneous isolation and quantitation of platelet activating factor and multiple arachidonate metabolites from small samples: analysis of effects of Staphylococcus aureus enterotoxin B in mice. Anal Biochem (1994) 0.82
Native lipoproteins inhibit platelet activation induced by oxidized lipoproteins. Biochem Biophys Res Commun (1996) 0.81
Characterization of type III intermediate filament regulatory protein target epitopes: S-100 (beta and/or alpha) binds the N-terminal head domain; annexin II2-p11(2) binds the rod domain. Biochim Biophys Acta (1996) 0.81
Identification of high-affinity (Kd 0.35 mumol/L) and low-affinity (Kd 7.9 mumol/L) platelet binding sites for ADP and competition by ADP analogues. Blood (1988) 0.81
Phosphoprotein, protein kinase C, and second-messenger system changes in human multidrug-resistant cancer cells. Cancer Treat Res (1989) 0.81
Isolation of human platelet plasma membranes by glycerol lysis. Methods Enzymol (1992) 0.80
Dictyostelium calmodulin: affinity isolation and characterization. Arch Biochem Biophys (1983) 0.80
Platelets in tumor metastasis: generation of adenosine diphosphate by tumor cells is specific but unrelated to metastatic potential. Blood (1988) 0.80
Studies on phytohemagglutinins. I. Some properties of the lectins of horse gram seeds (Dolichos biflorus L.). Biochim Biophys Acta (1977) 0.80